Pharma Slowly Adapting to Complexities and Challenges of Developing Personalized Medicine

This is the first of a two-part feature on the state of personalized drug development. The first part focuses on the scientific challenges facing the industry. The second part discusses the evolving regulatory and financial environment and recent advances in the field.